Dickmeyer Boyce Financial Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$664K Sell
23,284
-1,187
-5% -$31.6K 0.34% 71
2026
Q2
$589K Buy
24,471
+1,547
+7% +$40.5K 0.31% 77
2026
Q1
$644K Buy
+22,924
New +$610K 0.38% 67

Other funds holding PFE

Dickmeyer Boyce Financial Management's PFE Position: Q3 2026 in Review

Dickmeyer Boyce Financial Management reduced its Pfizer (PFE) stake by 4.9% in Q3 2026, selling an estimated $31.6K and leaving 23,284 shares worth $664K. The position accounts for 0.34% of the portfolio, ranked #71.

Dickmeyer Boyce Financial Management first reported a position in PFE in Q1 2026 and has held it in 3 quarters since. 101 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Dickmeyer Boyce Financial Management held 23,284 shares of Pfizer worth $664K as of Q3 2026.
  • Dickmeyer Boyce Financial Management sold 1,187 Pfizer shares in Q3 2026, an estimated $31.6K.
  • Pfizer made up 0.34% of Dickmeyer Boyce Financial Management's portfolio in Q3 2026, its #71 holding.
  • Dickmeyer Boyce Financial Management first reported a position in Pfizer in Q1 2026 and has held it in 3 quarters since.
  • 101 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Dickmeyer Boyce Financial Management's 13F filing for Q3 2026, filed 8 Oct 2026.